Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Smith

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Journal of Neuroinflammation|January 28, 2025
NLRX1 limits inflammatory neurodegeneration in the anterior visual pathwayAlexander J Gill, Matthew D Smith, Danny Galleguillos, et al.
Mabs|November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learningEmily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Cell Reports. Medicine|November 10, 2021
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolismKathryn C Fitzgerald, Matthew D Smith, Sol Kim, et al.
Scientific Reports|October 21, 2021
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screeningJohn S Schardt, Ghasidit Pornnoppadol, Alec A Desai, et al.
Frontiers in Immunology|October 29, 2025
Directed evolution of drug-like Aβ conformation-specific antibodiesAlec A Desai, Matthew D Smith, Jennifer M Zupancic, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with SeverityFatemeh Siavoshi, Julián Candia, Dimitrios C Ladakis, et al.
Nature|September 9, 2021
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosisMartina Absinta, Dragan Maric, Marjan Gharagozloo, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
PKC modulator bryostatin-1 therapeutically targets CNS innate immunity to attenuate neuroinflammation and promote remyelinationPayam Gharibani, Efrat Abramson, Shruthi Shanmukha, et al.
The Journal of Biological Chemistry|March 6, 2021
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificityAlec A Desai, Matthew D Smith, Yulei Zhang, et al.
Plos Biology|September 17, 2019
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunityMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Journal of Neuroinflammation|January 28, 2025
NLRX1 limits inflammatory neurodegeneration in the anterior visual pathwayAlexander J Gill, Matthew D Smith, Danny Galleguillos, et al.
Mabs|November 26, 2022
Reduction of therapeutic antibody self-association using yeast-display selections and machine learningEmily K Makowski, Hongwei Chen, Matthew Lambert, et al.
Cell Reports. Medicine|November 10, 2021
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolismKathryn C Fitzgerald, Matthew D Smith, Sol Kim, et al.
Scientific Reports|October 21, 2021
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screeningJohn S Schardt, Ghasidit Pornnoppadol, Alec A Desai, et al.
Frontiers in Immunology|October 29, 2025
Directed evolution of drug-like Aβ conformation-specific antibodiesAlec A Desai, Matthew D Smith, Jennifer M Zupancic, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with SeverityFatemeh Siavoshi, Julián Candia, Dimitrios C Ladakis, et al.
Nature|September 9, 2021
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosisMartina Absinta, Dragan Maric, Marjan Gharagozloo, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
PKC modulator bryostatin-1 therapeutically targets CNS innate immunity to attenuate neuroinflammation and promote remyelinationPayam Gharibani, Efrat Abramson, Shruthi Shanmukha, et al.
The Journal of Biological Chemistry|March 6, 2021
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificityAlec A Desai, Matthew D Smith, Yulei Zhang, et al.
Plos Biology|September 17, 2019
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunityMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Pageof 24